MammaPrint is primarily intended for patients with early-stage, invasive breast cancer. It is particularly useful for those with stage I or II cancer, where the tumor is 5cm or less in size, and for those with lymph node-negative or lymph node-positive (up to 3 positive nodes) cancer. Patients who fall within these categories can benefit from the test to make more informed treatment decisions.
